Probing the degradation of pharmaceuticals in urine using MFC and studying their removal efficiency by UPLC-MS/MS

被引:1
|
作者
Priya Sharma [1 ]
Devendra Kumar [2 ,3 ]
Srikanth Mutnuri [1 ]
机构
[1] Applied Environmental Biotechnology Laboratory, Birla Institute of Technology & Science (BITS)
[2] Central Sophisticated Instrumentation Facility, Birla Institute of Technology & Science (BITS)
[3] Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center
关键词
Pharmaceuticals; Urine; MFC; Biodegradation; Liquid chromatography mass spectroscopy;
D O I
暂无
中图分类号
X703 [废水的处理与利用]; TM911.45 [生物化学燃料电池、微生物燃料电池];
学科分类号
0808 ; 083002 ;
摘要
Nutrient recovery from source-separated human urine has attracted interest as it is rich in nitrogen and phosphorus that can be utilized as fertilizer. However, urine also contains pharmaceuticals, steroid hormones, etc. and their removal is crucial as they have detrimental effects on the environment and human health. The current study focuses on investigating the degradation of pharmaceuticals using a double-chamber microbial fuel cell(MFC). Urine was spiked with four pharmaceuticals(trimethoprim,lamivudine, levofloxacin, and estrone) at a concentration of 2 mg/mL. The MFC was operated for 7 months in batch mode with this spiked urine as feed. The degradation efficiency of the MFC was studied, for which a selective liquid chromatography-tandem mass-spectrometric method was developed for the quantitation of compounds used in the spiking experiments and was validated with a lower limit of quantification of 0.39 ng/mL. The maximum removal rate achieved was 96% ± 2%. The degradation mechanism involved processes like sorption and anoxic biodegradation. The voltage curve obtained showed that the presence of pharmaceuticals had an initial negative impact on power generation along with increased organic content; however, after the reactor acclimatization, increased power output was achieved with maximum organics removal at 30 h of retention time. This work opens a new perspective for the anoxic biodegradation of pharmaceuticals and can be useful in future bioremediation studies.
引用
收藏
页码:320 / 329
页数:10
相关论文
共 50 条
  • [21] Development of UPLC-MS/MS method for studying the pharmacokinetic interactions of fuzuloparib with curcumin in rats
    Wu, Hualu
    Xie, Saili
    Chen, Xiaohai
    Xia, Hailun
    Shen, Yuxin
    Xu, Ren-ai
    Tan, Wei
    Zhan, Ruanjuan
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 249
  • [22] Determination of urinary globotriaosylceramide by UPLC-MS/MS: Urine dried on filter paper versus liquid urine
    Forni, S.
    Fu, X.
    Sweetman, L.
    Schiffmann, R.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 124 - 124
  • [23] Comparison of matrix effects in HPLC-MS/MS and UPLC-MS/MS analysis of nine basic pharmaceuticals in surface waters
    Van De Steene, Jet C.
    Lambert, Willy E.
    JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2008, 19 (05) : 713 - 718
  • [24] Systematic development of an UPLC-MS/MS method for the determination of tricyclic antidepressants in human urine
    Chambers, Erin E.
    Woodcock, Matthew J.
    Wheaton, Jessalynn P.
    Pekol, Teresa M.
    Diehl, Diane M.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 88 : 660 - 665
  • [25] Neonatal Mass Urine Screening Approach for Early Detection of Mucopolysaccharidoses by UPLC-MS/MS
    Menkovic, Iskren
    Marchand, Anne-Sophie
    Boutin, Michel
    Auray-Blais, Christiane
    DIAGNOSTICS, 2019, 9 (04)
  • [26] Development and validation of UPLC-MS/MS method for icariin and its metabolites in mouse urine
    Li, Na
    Yuan, Mei
    Che, Jinjing
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Newborn mass urine screening for Morquio syndrome type A patients using an innovative UPLC-MS/MS approach
    Auray-Blais, Christiane
    Maranda, Bruno
    Lavoie, Pamela
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S26 - S26
  • [28] Quantification and Pharmacokinetics Study of Pedunculoside in Rats by Using UPLC-MS/MS
    Yang, Aiping
    Dong, Jiajia
    Zhao, Huimin
    Zhang, Qichun
    Zhu, Xuyu
    Gao, Lina
    Ding, Ning
    Li, Caihong
    Peng, Ren
    Lu, Tulin
    Hu, Lihong
    Wang, Xiachang
    CURRENT PHARMACEUTICAL ANALYSIS, 2021, 17 (06) : 731 - 737
  • [29] Pharmacokinetic Study on Hirsutine and Hirsuteine in Rats Using UPLC-MS/MS
    Han, Aixia
    Lin, Guanyang
    Cai, Jinzhang
    Wu, Qing
    Geng, Peiwu
    Ma, Jianshe
    Wang, Xianqin
    Lin, Chongliang
    ACTA CHROMATOGRAPHICA, 2019, 31 (02) : 99 - 104
  • [30] Accurate Determination of the Degree of Deacetylation of Chitosan Using UPLC-MS/MS
    Xue, Ting
    Wang, Wenqing
    Yang, Zhiyuan
    Wang, Fanjun
    Yang, Lei
    Li, Jian
    Gan, Hui
    Gu, Ruolan
    Wu, Zhuona
    Dou, Guifang
    Meng, Zhiyun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)